UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

E2NMB

NLBNPNL2JCI0

Market Closed - Euronext Paris 16:14:59 17/05/2024 BST
2.396 EUR +2.83% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month+19.26%
1 month+49.56%
Date Price Change
17/05/24 2.396 +2.83%
16/05/24 2.33 -4.12%
15/05/24 2.43 -0.57%
14/05/24 2.444 +3.08%
13/05/24 2.371 +2.15%

Real-time Euronext Paris

Last update May 17, 2024 at 04:14 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
E2NMB
ISINNLBNPNL2JCI0
Date issued 13/10/2023
Strike 70.37 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 1.96
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.528
Lowest since issue 1.376

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
107.9 USD
Spread / Average Target
+4.91%
Consensus
  1. Stock Market
  2. Certificates
  3. E2NMB Certificat